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Abstract We employed £uorescence correlation spectroscopy
(FCS) to analyze the characteristics of biomolecules in living
cells. Protein kinase C (PKC) changes its subcellular localiza-
tion from cytosol to the plasma membrane by its ligand. Using
FCS, we found PKCLI labeled with enhanced green £uorescent
protein freely di¡using in cytosol. Upon 12-O-tetradecanoyl-
phorbol-13-acetate activation, a large part of PKCLI is an-
chored in the plasma membrane but some PKCLI still moves
freely near the plasma membrane. These results indicate that a
di¡usion-driven transport mechanism is appropriate for the mo-
lecular mechanism of the PKCLI localization change.
, 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
Fluorescence correlation spectroscopy (FCS) is one of the
techniques used to assess protein interactions in aqueous con-
ditions at the single-molecule level [1]. FCS measures the £uc-
tuations in £uorescence intensity caused by £uorescent probe
movement in a small light cavity with a de¢ned volume (0.25
£) generated by confocal illumination. The average residence
time (d) and the absolute number of probes in the small vol-
ume can be deduced by the £uorescence autocorrelation func-
tion (FAF) calculated from measured £uctuations. FCS has
been used to inquire into the molecular kinetics of biophysical
and biochemical reactions in vitro [2^6]. FCS can also mea-
sure the kinetics of reactions and analysis of microenviron-
ment inside a single living cell [7^13].
Protein kinase C (PKC) is recognized as one of the key
enzymes in signal transduction and is related to the control
of many aspects of cellular function [14]. PKCLI, one of the
subtypes of conventional PKC, undergoes a localization
change from cytosol to the plasma membrane upon activation
by various intracellular signaling factors such as diacylglycerol
or phorbol ester (e.g. 12-O-tetradecanoylphorbol-13-acetate
(TPA)) [15,16]. Recent observations of PKC fused with green
£uorescent protein (GFP) under confocal scanning £uores-
cence microscopy in living cells have clearly revealed the sub-
cellular localization of each PKC subtype [17^19].
However, it is still unclear (i) whether PKCLI is free or
bound to another protein in cytosol before stimulation, (ii)
how PKCLI is ¢xed on the surface of the plasma membrane
after the localization change, and (iii) how PKCLI moves
from cytosol to the membrane and whether PKCLI needs
another protein for the localization change. These subjects
have not been studied using classical biological techniques.
By using FCS, we examined these aspects of PKCLI.
2. Materials and methods
2.1. Cell culture and transfection with plasmid DNA
Human embryonic kidney 293 (HEK293) cells were grown in a 5%
CO2 humidi¢ed atmosphere at 37‡C in Dulbecco’s modi¢ed Eagle’s
medium (DMEM) supplemented with 10% fetal bovine serum, 2U105
U/l penicillin G, and 200 mg/l streptomycin sulfate. Cells were propa-
gated every 1 or 2 days. For transient expression, cells were plated at
a con£uence of 10^20% on LAB-TEK chambered coverslips with
eight wells (Nalge Nunc International, Naperville, IL, USA) for 12 h
before transfection. DMEM (20 Wl) and FuGENE 6 (1.2 Wl, Roche
Molecular Biochemicals, Mannheim, Germany) were mixed. Five
minutes after mixing, 0.4 Wg of the EGFP-C1 or PKCLI-EGFP coding
plasmid DNA (Clontech, Palo Alto, CA, USA) was added to the
prediluted FuGENE 6 solution. The DNA solution was left for 15
min and added to one well at 12 h before FCS measurement.
2.2. Microscopy
Live cell £uorescence microscopy was performed using an LSM510
inverted confocal laser scanning microscope (LSM, Carl Zeiss, Jena,
Germany). EGFP was excited at the 488 nm laser line of a CW Arþ
laser through a water immersion objective (C-Apochromat, 40U, 1.2
NA; Carl Zeiss) with emission detected at s 505 nm. Pinhole diam-
eter was adjusted to 70 Wm.
2.3. FCS setup
FCS measurements were carried out with a ConfoCor and Confo-
Cor2 (Carl Zeiss) that consisted of a CW Arþ laser, a water immer-
sion objective (C-Apochromat, 40U, 1.2 NA; Carl Zeiss), an ava-
lanche photodiode (SPCM-200-PQ, EGpG, Quebec, QC, Canada)
and a digital correlator (ALV 5000/E, ALV, Langen, Germany) for
the ConfoCor. Confocal pinhole diameter was adjusted to 30 Wm and
70 Wm for the ConfoCor and ConfoCor2, respectively. Samples were
excited with about 10 kW/cm2 of laser power at 488 nm and the
£uorescence signal was detected through a dichroic mirror (s 510
nm) and a band pass ¢lter (515^560 nm).
2.4. FCS measurement and analysis
Cells were washed with phenol red-free Hanks’ balanced salt solu-
tion (HBSS) two times to remove phenol red dye, then medium was
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replaced by HBSS. Immediately thereafter, FCS measurements were
carried out. PKCLI activation was done by addition of 30 ng/ml TPA
solution to the medium. FAFs, G(d), were acquired online with a
digital correlator and ¢tted with the FCS Access Fit program (EVO-
TEC BioSystems, Hamburg, Germany) by a one-, two-, or three-com-
ponent model as follows:
Gðd Þ ¼ GIðtÞIðtþ d Þf
GIðtÞf2
¼ 1þ 1
N
X
i
F i 1þ dd i
 
31 1þ d
s2d i
 
31=2 ð1Þ
where Fi and di are the fraction and di¡usion time of component i,
respectively, N is the number of £uorescent molecules in the detection
volume element de¢ned by radius w0 and length 2z0, s is the structure
parameter representing the ratio, s= z0/w0. FAFs of rhodamine 6G
(Rh6G) solution were measured for 60 s ¢ve times at 10-s intervals,
then the di¡usion time (dRh6G) and s were obtained by one-component
¢tting of the measured FAFs. Di¡usion constants of samples (Dsample)
were calculated from the ratio with the di¡usion constant of Rh6G
DRh6G (2.8U1036 cm2/s) and di¡usion times dRh6G and dsample were
obtained as the following equation:
Dsample
DRh6G
¼ dRh6G
d sample
ð2Þ
3. Results
3.1. PKCLI-EGFP localization changes upon TPA activation
To observe the localization of EGFP and PKCLI-EGFP in
HEK293 cells, confocal LSM images of HEK293 cells were
taken and the £uorescence intensity of the confocal volume
element according to the optical axis (z-scan) was measured.
Images of HEK293 cells expressing EGFP and PKCLI-EGFP
are shown in Fig. 1A. EGFP was widely distributed through
the cytosol and nucleus. Even 10 min after TPA addition, the
localization of EGFP was not changed. On the other hand,
PKCLI-EGFP was mainly located in the cytosol but was also
found in the plasma membrane. However, 10 min after TPA
addition PKCLI-EGFP was mainly located in the plasma
membrane.
The time course of £uorescence intensity distribution along
the optical axis (z-scan) in transfected HEK293 cells is shown
in Fig. 1B. In a control experiment the £uorescence intensity
of EGFP was not changed even after TPA addition. Initially,
that of PKCLI-EGFP was distributed through the cytosol.
After TPA addition, the £uorescence intensity pro¢le had
two peaks at both sides of the membrane. From them, we
could choose the measuring position of the cytosol and plas-
ma membrane using the 2D image of LSM and also the opti-
cal axis scan (z-scan) of FCS (Fig. 1C).
3.2. FCS measurements for EGFP in living cells and in
TE bu¡er
We measured FAFs of EGFP in living cells. Example FAFs
are shown in Fig. 2. FCS measurements were carried out from
the plasma membrane to cytosol in about 1-Wm steps (Fig.
2A). In the plasma membrane region, since the plasma mem-
brane is very thin (V4 nm), the confocal volume contains
both cytosol and membrane, where fast and slow components
may coexist. However, similar correlation curves were also
obtained at positions 1 (membrane) to 4 (cytosol) (Fig. 2C).
Because EGFP does not interact with plasma membrane,
there was no contribution from interaction with the plasma
membrane. Therefore, most of the fraction was free-moving
molecules, which were observed even at position 1.
All FAFs for in vitro measurements could be ¢tted to one
component. See, for example, TE measurement in Fig. 2C.
However, for in vivo measurements, the number of compo-
nents was not pre-¢xed since the state of the target molecules
in living cells was unknown. Thus in vivo measurements could
be ¢tted not only to one component but to two or three
components according to the £ow chart of the evaluation
procedure reported previously [12]. We also analyzed £uores-
cence autocorrelation functions in a model that included 2D
and 3D components. The parameters (di¡usion constant and
fraction) obtained from this analysis were not so di¡erent
from those in the analysis in the model that included 3D
components only. Therefore in this study, we used the model
that included 3D components only. The averages of the dif-
fusion constants and fractions of EGFP in the cytosol and in
the plasma membrane region are shown in Table 1. More
Fig. 1. Localization and translocation of PKCLI-EGFP. A: Trans-
fected HEK293 cells with EGFP (left) and PKCLI-EGFP (right)
were imaged using a confocal LSM before (upper) and 10 min after
(lower) TPA addition. Scale bars represent 10 Wm. B: The z-scan
time course through transfected HEK293 cells was observed after
TPA addition. C: The z-scan was performed using an FCS system.
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than 95% of the fraction of EGFP in the cytosol was de¢ned
as the ¢rst component, which means free di¡usion. These
results were highly reproducible and independent within the
cytosol position. The ¢rst components are presumed to repre-
sent the freely di¡using EGFP in cytosol. The second compo-
nents are considered to represent the slowly di¡using EGFP.
The high density of the cellular solute may prevent free, rapid
di¡usion of EGFP. The third components might represent the
Fig. 2. Di¡usion of EGFP. A: EGFP-transfected HEK293 cell and
measurement positions. Scale bar represents 10 Wm. B: FAF of
EGFP at the measurement positions from the plasma membrane to
cytosol in about 1-Wm steps. Numbers of measurement positions
shown in A correspond to numbers in B. C: Normalized FAF of B
and that in TE bu¡er.
Table 1
Di¡erence between subcellular location and e¡ect of TPA addition on the di¡usion of EGFP
First Second Third
n D1 (cm2/s) F1 (%) D2 (cm2/s) F2 (%) D3 (cm2/s) F3 (%)
Cytosol
TPA(3) 133 2.5T 1.0U1037*2 98.6 9.1T 9.4U1039 1.4 ^ ^
TPA(+) 85 2.4T 0.8U1037 97.5 1.0T 1.3U1038 2.4 2.8U1039 0.1
Membrane
TPA(3) 90 2.4T 1.1U1037 96.2 9.4T 8.8U1039 3.6 2.9U10311 0.2
TPA(+) 77 2.5T 1.2U1037 92.9 1.2T 1.2U1038 6.8 3.8U10311 0.2
TE bu¡er 13 8.9T 0.5U1037* 100 ^ ^ ^ ^
The di¡usion constants (D), fraction (F) and number (n) of FCS measurements for EGFP in cytosol and in the plasma membrane region in
the absence (TPA(3)) and presence (TPA(+)) of TPA and of EGFP in TE bu¡er.
*Signi¢cantly di¡erent (P6 0.001). 2Signi¢cantly di¡erent (P6 0.001) between Tables 1 and 2.
 
Fig. 3. Di¡usion of PKCLI-EGFP. A: PKCLI-EGFP-transfected
HEK293 cell and measurement positions. Scale bar represents 10
Wm. B: FAF of PKCLI-EGFP at the measurement positions from
the plasma membrane to cytosol in about 1-Wm steps. Numbers of
measurement positions shown in A correspond to numbers in B.
C: Normalized FAF of B.
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apparent di¡usion caused by a £uorescence intensity decrease.
There was no signi¢cant di¡erence between the average D1 of
EGFP in cytosol and that in the plasma membrane region, as
the membrane contribution to mobility was very small even in
the plasma membrane region, as shown in Fig. 2B,C. Nor was
there any signi¢cant di¡erence between the average D1 of
EGFP in the absence and presence of TPA. D1 of EGFP in
cytosol was about three times smaller than that in TE bu¡er.
This result indicates that the viscosity of the cytosol was only
about three times that in TE bu¡er.
3.3. FCS measurements for PKCLI-EGFP in living cells
We also measured FAFs of PKCLI-EGFP in living cells. In
the FCS measurement, we targeted not brightly £uorescent
cells but weakly £uorescent ones because FCS has a high
sensitivity. For example, the cell on the left in Fig. 3A was
not suitable for FCS measurement, so we carried out FCS
measurement in the cell on the right. Typical FAFs are shown
in Fig. 3. FCS measurements were carried out from the plas-
ma membrane to cytosol in about 1-Wm steps (Fig. 3A). There
were no signi¢cant di¡erences between the FAF of PKCLI-
EGFP at positions from the plasma membrane to cytosol in
the absence of TPA (Fig. 3B,C). However, after TPA addition
to the same cell (Fig. 4A), the amplitude of FAF increased
from the plasma membrane to the cytosol, which meant a
decrease of the mean number GNf of PKCLI-EGFP molecules
from the plasma membrane to cytosol, which agreed with the
translocation of the protein (Fig. 4B). In the plasma mem-
brane region (position 1), FAF di¡ered from those of the
others, a typical multicomponent function (Fig. 4C). On the
other hand, positions 2^4 were similar to the FAFs before
TPA addition.
Fig. 5 shows the dispersion plots of D and the fraction from
FCS measurements of PKCLI-EGFP. All obtained plots were
distributed mainly into two clusters. The ¢rst components
were grouped into one cluster between 1037 and 1036 cm2/s
and presumed to represent the free di¡usion of PKCLI-EGFP
in cytosol. The second components were between 10311 and
5U1038 cm2/s and considered to represent the slow di¡usion
of PKCLI-EGFP that interacted with inner cellular compo-
nents and the plasma membrane. Actually, we cannot detect
immobile complexes by using FCS, but we can estimate the
fraction of the immobile component from the degree of pho-
tobleaching during FCS measurement. However, a detailed
discussion and studies about photobleaching in FCS measure-
ment are beyond the focus of this paper. In the absence of
TPA, the distributions of D in cytosol and in the plasma
membrane were similar. However, in the presence of TPA,
at the plasma membrane region the plots of the clusters be-
tween 10311 and 5U1038 cm2/s shifted to an increase (Fig.
5D, white arrow), and the number of plots of the cluster
between 1037 and 1036 cm2/s decreased (Fig. 5D, dark ar-
row).
The averages of the di¡usion constants and fractions of
PKCLI-EGFP in the cytosol and that in the plasma mem-
brane region are shown in Table 2. The D1 values of non-
Fig. 4. Di¡usion of PKCLI-EGFP after TPA addition. A: PKCLI-
EGFP-transfected HEK293 cell after TPA addition and measure-
ment positions. B: FAF of PKCLI-EGFP at the measurement posi-
tions from the plasma membrane to cytosol in about 1-Wm steps.
Numbers of measurement positions shown in A correspond to num-
bers in B. C: Normalized FAF of B. Mean numbers GNf of PKCLI-
EGFP molecules obtained from FAFs were 12.7, 7.1, 2.8 and 1.4 at
positions 1^4, respectively.
Fig. 5. Statistical analysis of di¡usion constants. Dispersion plots of
di¡usion constants and their fractions from FCS measurements for
PKCLI-EGFP in cytosol and in the plasma membrane region in the
absence (TPA(3)) and presence (TPA(+)) of TPA. First, second
and third components are shown with di¡erent symbols.
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activated PKCLI-EGFP in cytosol and in the plasma mem-
brane region were similar to each other and were about 1.4
times slower than that of EGFP. This D1 ratio agreed with the
predicted value calculated from the cube root of EGFP and
the PKCLI-EGFP molecular weight ratio, according to the
Stokes^Einstein equation. F1 and F2 in the plasma membrane
were changed after TPA addition. The F1 in the plasma mem-
brane became 53.9% and the F2 in the plasma membrane
region became 42.1% (Table 2). A possible explanation for
the larger changes in D1 in cytosol in the presence of TPA
is an apparent increase of D caused by a decrease of £uores-
cence intensity. We could not measure the precise di¡usion
constant on PKCLI-EGFP in cytosol in the presence of
TPA because of the low £uorescence intensity and low S/N
ratio.
4. Discussion
We applied £uorescence correlation spectroscopy to mea-
sure the di¡usion of PKCLI in the living cell. First, we ob-
served the di¡usion of PKCLI in cytosol in the inactive state.
The measured D1 agreed with the predicted value calculated
from the cube root of EGFP and the PKCLI-EGFP molecular
weight ratio, according to the Stokes^Einstein equation. Thus,
like EGFP, PKCLI in the inactive state was not bound with
other proteins or macromolecules in cytosol or near the plas-
ma membrane.
Second, we measured the di¡usion of PKCLI after the lo-
calization change. As seen in Figs. 4 and 5, a signi¢cant
amount of translocated PKCLI near the plasma membrane
still moved freely. There might have been reversible binding
of PKCLI to the plasma membrane surface in the presence of
TPA. Our results directly con¢rm the model for PKCLI trans-
location previously proposed [20] with respect to the weak
interaction in unstimulated cells between PKCLI and an an-
choring component (Fig. 5B, Table 2). After PKCLI trans-
located to the plasma membrane, the fraction of slow move-
ment (second component) that interacted with the plasma
membrane increased from 16.7% to 42.1% (Fig. 5D, Table
2). Thus, there might have been lateral di¡usion of mem-
brane-bound PKCLI. Some reports have suggested that
PKCLI interacts primarily with the surface of the lipid mem-
brane, and others have proposed that PKCLI binds mem-
brane-anchoring proteins (receptor for activated C kinase or
RACKs) and then phosphorylates its substrates [15,16,20].
The rather wide range of D2 of PKCLI-EGFP at the plasma
membrane in the presence of TPA (Fig. 5D) showed that
PKCLI might interact with membrane lipids (TPA, phospha-
tidylserine) and/or RACKs. PKCLI might have been localized
on the plasma membrane by reversible binding of PKCLI to
the plasma membrane and/or lateral di¡usion at the plasma
membrane. However, further study is needed to detect the
direct interaction between PKCLI and its ligand by means
of dual-color £uorescence cross-correlation spectroscopy [21].
Finally, we will discuss the mechanism of the PKCLI local-
ization change from cytosol to the plasma membrane. The
PKCLI localization change does not need speci¢c biochemical
systems, such as cytoskeleton or energy-dependent motor pro-
teins that are essential for some types of protein tra⁄cking,
for example, axonal £ow and vesicle transport [17]. In human
erythrocytes, which do not have a transport system, an in-
crease of PKC activity in the plasma membrane was demon-
strated [22]. Although a di¡usion-driven translocation mech-
anism was found by confocal line-scan microscopy to follow
subcellular PKC concentrations at high spatiotemporal reso-
lution [23], this measurement still required overexpression of
PKC. In contrast, FCS measurement can be carried out in
diluted conditions (see Fig. 3A) so that our results represent
a more native condition of PKC in the living cell. In this study
we found that inactive PKCLI moved rapidly in cytosol
(D1 = 1.8U1037 cm2/s). Assuming a random walk by di¡u-
sion, it would take about 2.5 s to travel a distance of 10 Wm,
which is about the distance from the center of a cell to the
plasma membrane. This calculation indicates that a di¡usion-
driven transport mechanism is appropriate for the molecular
mechanism of the PKC localization change. Upon TPA acti-
vation, PKC freely di¡uses in cytosol and often collides with
TPA in the plasma membrane. PKCLI is anchored in the
plasma membrane when successful binding events between
PKCLI and TPA occur. Our results were obtained from
only HEK293 cells. We plan to examine another cell line in
order to con¢rm our results in a future experiment.
These aspects of PKCLI were not clari¢ed by using classical
biological techniques. Thus, FCS is a useful tool for investi-
gating the molecular mechanism of dynamic events like the
PKCLI localization change in living cells.
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